Yearly Archives - 2019

Dan Feinberg: A CES 2019 Preview

The Saturday before CES begins is a transition day here in Las Vegas. The weekend sports fans and partygoers are leaving, and floods of techies from around the world are pouring in. This afternoon, a number of the very first 2019 public relation gatherings—showing mostly startup companies—are open to the press. Read more >>

Corbus Pharmaceuticals Announces Strategic Collaboration with Kaken Pharmaceutical Co., Ltd. to Develop and Commercialize Lenabasum in Japan for Systemic Sclerosis and Dermatomyositis

Corbus Pharmaceuticals Holdings, Inc. announced today that they have entered into a strategic collaboration with Kaken Pharmaceutical Co., Ltd. (“Kaken”) for the development and commercialization in Japan of Corbus’ investigational drug lenabasum for the treatment of systemic sclerosis (“SSc”) and dermatomyositis (“DM”), two rare and serious autoimmune diseases. Read more >>